Use of androgenic anabolic steroids before and during the Olympic Games: Less but not died out;Gebruik van androgene anabole steroïden voor en tijdens de Olympische Spelen: Verminderd, maar niet verdwenen

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 33, 2008, Pages 1820-1824

  De Ronde, W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; TESTOSTERONE;

ARTICLE; COMPETITION; DOPING; DRUG MISUSE; GERMANY; GOVERNMENT REGULATION; HUMAN; MOTOR PERFORMANCE; SPORTS MEDICINE;

ANABOLIC AGENTS; ANDROGENS; DOPING IN SPORTS; FEMALE; GERMANY, EAST; HUMANS; MALE; MASS SCREENING; TRACK AND FIELD;

EID: 50149089792     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem. 1996;42:1001-20.
2. Wu FC. Endocrine aspects of anabolic steroids. Clin Chem. 1997;43:1289-92.
3. Wilson JD. Androgen abuse by athletes. Endocr Rev. 1988;9:181-99.
4. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem. 1997;43:1262-79.
5. Cowan DA, Kicman AT. Doping in sport: misuse, analytical tests, and legal aspects. Clin Chem. 1997;43:1110-3.
6. Brooks RV, Firth RG, Sumner NA. Detection of anabolic steroids by radioimmunoassay. Br J Sports Med. 1975;9:89-92.
7. Catlin DH, Hatton CK, Starcevic SH. Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes' urine. Clin Chem. 1997;43:1280-8.
8. Death AK, McGrath KC, Kazlauskas R, Handelsman DJ. Tetrahydrogestrinone is a potent androgen and progestin. J Clin Endocrinol Metab. 2004;89:2498-500.
9. Knight J. Drugs bust reveals athletes' secret steroid. Nature. 2003;425:752.
10. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom. 2004;18:1245-9.